Citi Bonus Zert MRK 25.06.2024/ DE000KH21H49 /
6/19/2024 9:17:42 AM | Chg.- | Bid10:00:04 PM | Ask10:00:04 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
168.37EUR | - | - Bid Size: - |
- Ask Size: - |
MERCK KGAA O.N. | - - | 6/25/2024 | Call |
GlobeNewswire
2:00 PM
Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in...
GlobeNewswire
6/20
Pioneering Support for Working Parents: INVNT GROUP Becomes First Global Agency to Partner with Milk...
GlobeNewswire
6/3
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
5/29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA